Resveratrol Counteracts Inflammation in Human M1 and M2 Macrophages upon Challenge with 7-Oxo-Cholesterol: Potential Therapeutic Implications in Atherosclerosis

Oxidative Medicine and Cellular Longevity - Tập 2014 - Trang 1-12 - 2014
Brigitta Buttari1, Elisabetta Profumo1, Luca Segoni1, Daniela D’Arcangelo2, Stefania Rossi3, Francesco Facchiano3, Luciano Saso4, Rita Businaro5, Luigi Iuliano5, Rachele Riganò1
1Department of Infectious, Parasitic and Immune-Mediated Diseases, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy
2Laboratory of Vascular Pathology, Istituto Dermopatico dell’Immacolata, IDI-IRCCS, 00167 Rome, Italy
3Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy
4Department of Physiology and Pharmacology “Vittorio Erspamer”, La Sapienza University of Rome, 00181 Rome, Italy
5Department of Medico-Surgical Sciences and Biotechnology, Sapienza University of Rome, 04100 Latin, Italy

Tóm tắt

Macrophages consist of two main subsets: the proinflammatory M1 subset and the anti-inflammatory M2 one. 7-oxo-cholesterol, the most abundant cholesterol autoxidation product within atherosclerotic plaque, is able to skew the M1/M2 balance towards a proinflammatory profile. In the present study, we explored the ability of the polyphenolic compound resveratrol to counteract the 7-oxo-cholesterol-triggered proinflammatory signaling in macrophages. Resveratrol-pretreated human monocyte-derived M1 and M2 macrophages were challenged with 7-oxo-cholesterol and analyzed for phenotype and endocytic ability by flow cytometry, for metalloproteinase- (MMP-) 2 and MMP-9 by gelatin zymography, and for cytokine, chemokine, and growth factor secretome by a multiplex immunoassay. We also investigated the NF-κB signaling pathway. In the M1 subset, resveratrol prevented the downregulation of CD16 and the upregulation of MMP-2 in response to 7-oxo-cholesterol, whereas in M2 macrophages it prevented the upregulation of CD14, MMP-2, and MMP-9 and the downregulation of endocytosis. Resveratrol prevented the upregulation of several proinflammatory and proangiogenic molecules in both subsets. We identified modulation of NF-κB as a potential mechanism implicated in 7-oxo-cholesterol and resveratrol effects. Our results strengthen previous findings on the immunomodulatory ability of resveratrol and highlight its role as potential therapeutic or preventive compound, to counteract the proatherogenic oxysterol signaling within atherosclerotic plaque.

Từ khóa


Tài liệu tham khảo

10.1038/ni.2001

10.1038/nature10146

10.1155/2012/693083

10.1016/j.bcp.2013.01.025

2012, Antioxidants & Redox Signaling, 17, 1785, 10.1089/ars.2012.4638

10.1038/nri2448

10.1016/j.immuni.2010.05.007

10.1002/eji.200636788

10.1146/annurev.immunol.021908.132532

10.1016/B978-0-12-417028-5.00006-5

10.1111/j.1742-4658.2005.04723.x

1997, Circulation, 95, 723, 10.1161/01.CIR.95.3.723

10.1016/S1537-1891(02)00174-X

10.1016/j.freeradbiomed.2007.04.033

10.1016/j.bcp.2013.04.008

10.1177/011542650802300149

2012, Frontiers in Pharmacology, 3, 141

10.1182/blood-2010-12-325514

10.1155/2013/574029

2014, Food & Function, 5, 74, 10.1039/C3FO60236B

10.4049/jimmunol.0713732

10.1007/s11033-012-2478-y

10.1146/annurev.immunol.021908.132620

10.1177/1753425913507096

10.1038/nri3073

10.1016/S1286-4579(00)01362-9

10.1073/pnas.0809784106

10.1007/s10456-012-9285-x

10.1038/nm.2538

10.1111/j.1471-4159.2011.07594.x

10.1002/mnfr.201100374

10.1016/j.atherosclerosis.2011.03.042

10.1017/S0007114511007057

10.1016/j.jss.2011.07.041

2011, Anatomy & Cell Biology, 44, 194, 10.5115/acb.2011.44.3.194

2012, PloS ONE, 7

2012, Lipids in Health and Disease, 11, article 76

10.1038/cr.2011.13

10.1016/j.placenta.2010.12.007

10.1016/j.jnutbio.2008.10.002

10.1016/j.jnutbio.2010.02.003

10.1371/journal.pone.0032195

10.1111/nyas.12150

10.1016/j.bcp.2013.10.006

Thông tin
Thông tin xuất bản

Oxidative Medicine and Cellular Longevity

Tập 2014

1-12

Thông tin tác giả